COCH (Envoy Medical) Research & Development: $13.38 Mil (TTM As of Mar. 2026)


COCH Envoy Medical Inc COCH
24 GF Score
Price $0.67
GF Value $1.14
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Envoy Medical Research & Development?

Envoy Medical COCH -0.70% 24 Research & Development is $13.38 Mil as of Mar. 2026. GuruFocus rates COCH with a GF Score™ of 24/100 and a GF Value™ of $1.14 (Possible Value Trap). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Envoy Medical's Research & Development for the three months ended in Mar. 2026 was $3.64 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $13.38 Mil.

Envoy Medical  (NAS:COCH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Envoy Medical Research & Development Related Terms

Envoy Medical Research & Development Historical Data

* Premium members only.

The historical data trend for Envoy Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Envoy Medical Research & Development Chart

Envoy Medical Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
3.94 4.98 8.96 10.18 12.49

Envoy Medical Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.75 2.49 2.70 4.55 3.64
COCH
24GF Score
Envoy Medical Inc COCH
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Envoy Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $13.38 Mil mean?
Envoy Medical (COCH) has a Research & Development of $13.38 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Envoy Medical and its competitors.
Is Envoy Medical's Research & Development too high?
Envoy Medical's current Research & Development is $13.38 Mil. Overall, Envoy Medical has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Envoy Medical's Research & Development compare to ELUT and SRTS?
Envoy Medical's Research & Development of $13.38 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Envoy Medical and its competitors. Envoy Medical's current Research & Development is $13.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envoy Medical stock overvalued right now?
Based on GuruFocus' analysis, Envoy Medical (COCH) is currently considered Possible Value Trap. The stock's GF Value™ is $1.14, compared to a current price of $0.67 — trading 41.3% below its estimated fair value. The current Research & Development is $13.38 Mil. Envoy Medical's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Envoy Medical (COCH), the current Research & Development is $13.38 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Envoy Medical (COCH) Overvalued in 2026?

Based on GuruFocus' analysis, Envoy Medical stock appears to be undervalued. The current stock price of $0.67 is trading 41.3% below its estimated GF Value™ of $1.14. GuruFocus considers Envoy Medical to be Possible Value Trap.

Key valuation signals for COCH:

  • Research & Development: $13.38 Mil
  • GF Value™: $1.14 vs. price of $0.67 (41.3% below fair value)
  • GF Score™: 24/100 with 6 warning signs

No single metric tells the full story. See the COCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Envoy Medical Business Description

Address 4875 White Bear Parkway, White Bear Lake, MN, USA, 55110
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
24GF Score

Get the complete analysis for COCH

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.67
Price
$1.14
GF Value